Newsquawk Logo

European Equity pre-Market Summary - 22nd September 2026: Futures indicate a slightly firmer cash open; Roche meets primary endpoints

Newsquawk StaffPublished On the live feed at — 2 more headlines followed before this page went public
Newsquawk headlinesUTC

Borsa Istanbul has removed Destek Finans Faktoring AS (DSTKF TU) and Katilimevim Tasarruf Finansman AS (KTLEV TU) from the Borsta Istanbul 100 index amidst a regulatory crackdown, Bloomberg reports

Saudi's Aramco has reportedly told Asian refiners that they will be able to pick up oil from Yanbu soon, Bloomberg reports citing sources

European Equity pre-Market Summary - 22nd September 2026: Futures indicate a slightly firmer cash open; Roche meets primary endpoints

Israeli security source says the situation with Iran is sensitive and unstable, adding that the Iranians do not appear ready to back down and the situation could spiral out of control, according to Tasnim citing Israel’s Channel 12

Iranian Islamic World Peace Forum Secretary General says a path to negotiations can open if the US accepts Iran’s terms and respects its rights, adding that otherwise Iran will continue to resist, IRIB News reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.

Earnings:

  • Bureau Veritas (BVI FP), +2.7%: Co. raises its 2027-28 total revenue CAGR to double-digit growth (prev. guided high-single-digit) and narrows its leverage range to 1.5-2x (prev. guided 1-2x).
  • Kingfisher (KGF LN), +2%: Reported H1 26/27 earnings which saw Total Sales match expectations, whilst Adj. Pretax Profit beat. Raised FY26/27 Adj. PBT guidance, and announced an interim dividend of 3.8P/shr.

Stories:

  • BASF (BAS GY), Evonik Industries (EVK GY): BASF reportedly explored a potential deal with Evonik earlier in 2026, Dealreporter reports citing sources.
  • Roche (ROP SW), +1%: Co. announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity, meeting both primary endpoints.

Broker Moves:

  • Burberry (BRBY LN), -2% downgraded to Sector Perform from Outperform at RBC.
  • LVMH (MC FP), -1% downgraded to Sector Perform from Outperform at RBC, PT cut to EUR 475 from EUR 575.
  • Ericsson (ERICB SS), -2.1% downgraded to Underweight from Equal Weight at Morgan Stanley.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.